| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762503075P | 2017-05-08 | 2017-05-08 | |
| US201762540734P | 2017-08-03 | 2017-08-03 | |
| US201762587030P | 2017-11-16 | 2017-11-16 | |
| PCT/US2018/031376WO2018208665A1 (en) | 2017-05-08 | 2018-05-07 | Engineered ligase variants |
| Publication Number | Publication Date |
|---|---|
| SG11201909957TAtrue SG11201909957TA (en) | 2019-11-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201909957TSG11201909957TA (en) | 2017-05-08 | 2018-05-07 | Engineered ligase variants |
| Country | Link |
|---|---|
| US (1) | US12344872B2 (en) |
| EP (2) | EP3635101B1 (en) |
| JP (2) | JP7401902B2 (en) |
| KR (1) | KR20200003903A (en) |
| CN (1) | CN110914415B (en) |
| AU (1) | AU2018266606B2 (en) |
| BR (1) | BR112019023337A2 (en) |
| CA (1) | CA3062550A1 (en) |
| DK (1) | DK3635101T3 (en) |
| ES (1) | ES2887078T3 (en) |
| HU (1) | HUE055411T2 (en) |
| MX (1) | MX2019013289A (en) |
| PL (1) | PL3635101T3 (en) |
| SG (1) | SG11201909957TA (en) |
| WO (1) | WO2018208665A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10837009B1 (en) | 2017-12-22 | 2020-11-17 | New England Biolabs, Inc. | DNA ligase variants |
| EP3906318A1 (en) | 2019-01-06 | 2021-11-10 | 10X Genomics, Inc. | Methods and systems for enrichment of barcodes |
| CN113811619A (en) | 2019-03-27 | 2021-12-17 | 10X基因组学有限公司 | Systems and methods for processing RNA from cells |
| CN113774032B (en)* | 2021-11-12 | 2022-03-01 | 翌圣生物科技(上海)股份有限公司 | Recombinant T4 ligase mutant, coding DNA and NGS library construction method |
| US20230212550A1 (en)* | 2021-12-02 | 2023-07-06 | Abclonal Science, Inc. | T4 DNA Ligase Variants with Increased Ligation Efficiency |
| US11685913B1 (en)* | 2022-02-18 | 2023-06-27 | Abclonal Science, Inc. | T4 DNA ligase variants with increased resistance to salt |
| US11788082B2 (en)* | 2022-02-22 | 2023-10-17 | Abclonal Science, Inc. | T4 DNA ligase variants with increased thermostability |
| US12416044B2 (en)* | 2022-03-21 | 2025-09-16 | Abclonal Science, Inc. | T4 DNA ligase variants with increased ligation efficiency |
| AU2023391614A1 (en)* | 2022-12-05 | 2025-07-17 | Twist Bioscience Corporation | Enzymes for library preparation |
| CN115896047B (en)* | 2022-12-12 | 2023-06-16 | 南京诺唯赞生物科技股份有限公司 | Recombinant T4DNA ligase mutant, fusion protein and application thereof |
| CN120476200A (en)* | 2022-12-30 | 2025-08-12 | 深圳华大生命科学研究院 | Nucleic acid ligase and application thereof |
| CN116218953B (en)* | 2023-01-03 | 2024-08-09 | 南京诺唯赞生物科技股份有限公司 | Method for connecting nucleic acid fragment and adaptor |
| WO2024158764A1 (en)* | 2023-01-23 | 2024-08-02 | Codexis, Inc. | Engineered dna ligase variants |
| WO2024235696A1 (en) | 2023-05-12 | 2024-11-21 | F. Hoffmann-La Roche Ag | Enzymatic conversion of methylated nucleic acids for sequencing |
| CN117946985B (en)* | 2024-03-27 | 2024-05-28 | 翌圣生物科技(上海)股份有限公司 | Mutant T4 DNA ligase, kit and application thereof in library construction |
| CN118879647B (en)* | 2024-07-31 | 2025-05-23 | 翌圣生物科技(上海)股份有限公司 | Mutant T4 DNA ligase and kit |
| CN118895257B (en)* | 2024-07-31 | 2025-05-23 | 翌圣生物科技(上海)股份有限公司 | T4 DNA ligase mutant and application thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582802A (en) | 1983-09-30 | 1986-04-15 | The United States Of America As Represented By The Department Of Health And Human Services | Stimulation of enzymatic ligation of DNA by high concentrations of nonspecific polymers |
| US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| CA2191718A1 (en) | 1994-06-03 | 1995-12-14 | Randy M. Berka | Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
| JP3167729B2 (en) | 1994-06-30 | 2001-05-21 | ノボ ノルディスク バイオテック，インコーポレイティド | Non-toxic, non-toxic, non-pathogenic expression systems and promoters and terminators for use therein |
| FI104465B (en) | 1995-06-14 | 2000-02-15 | Valio Oy | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| JP4062366B2 (en) | 1997-01-17 | 2008-03-19 | マキシジェン，インコーポレイテッド | Evolution of whole cells and organisms by recursive sequence recombination |
| US6265201B1 (en) | 1997-01-17 | 2001-07-24 | Regents Of The University Of Minnesota | DNA molecules and protein displaying improved triazine compound degrading ability |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| US7148054B2 (en) | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| WO1999029902A1 (en) | 1997-12-08 | 1999-06-17 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| US6484105B2 (en) | 1998-04-02 | 2002-11-19 | Maxyag, Inc. | Method for obtaining a plant with a genetic lesion in a gene sequence |
| KR20010082543A (en) | 1998-05-01 | 2001-08-30 | 추후제출 | Optimization of pest resistance genes using dna shuffling |
| WO1999065927A2 (en) | 1998-06-17 | 1999-12-23 | Maxygen, Inc. | Method for producing polynucleotides with desired properties |
| US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
| EP1104459A1 (en) | 1998-08-12 | 2001-06-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
| EP1119616A2 (en) | 1998-10-07 | 2001-08-01 | Maxygen, Inc. | Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| WO2000028018A1 (en) | 1998-11-10 | 2000-05-18 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes |
| JP4221100B2 (en) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | Semiconductor device |
| US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
| US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
| US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
| US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
| US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| EP1108783A3 (en) | 1999-01-19 | 2001-09-05 | Maxygen, Inc. | Oligonucleotide-mediated nucleic acid recombination |
| JP2003524394A (en) | 1999-02-11 | 2003-08-19 | マキシジェン， インコーポレイテッド | High-throughput mass spectrometry |
| EP1165757A1 (en) | 1999-03-05 | 2002-01-02 | Maxygen, Inc. | Encryption of traits using split gene sequences |
| US6703240B1 (en) | 1999-04-13 | 2004-03-09 | Maxygar, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
| US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| US6519065B1 (en) | 1999-11-05 | 2003-02-11 | Jds Fitel Inc. | Chromatic dispersion compensation device |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| JP2003519495A (en) | 2000-01-11 | 2003-06-24 | マキシジェン， インコーポレイテッド | Integrated systems and methods for diversity generation and screening |
| EP1272967A2 (en) | 2000-03-30 | 2003-01-08 | Maxygen, Inc. | In silico cross-over site selection |
| CA2405063C (en) | 2000-04-03 | 2013-06-04 | Maxygen, Inc. | Subtilisin variants |
| US7747391B2 (en) | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| AU2003216507A1 (en) | 2002-03-01 | 2003-09-16 | Maxygen, Inc. | Methods, systems, and software for identifying functional bio-molecules |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| WO2003078583A2 (en) | 2002-03-09 | 2003-09-25 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
| EP1654354A1 (en) | 2003-08-11 | 2006-05-10 | Codexis, Inc. | Improved ketoreductase polypeptides and related polynucleotides |
| HUE034642T2 (en) | 2008-02-12 | 2018-02-28 | Codexis Inc | Method of selecting an optimized diverse population of variants |
| EP2250594B1 (en) | 2008-02-12 | 2017-04-19 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
| US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
| US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
| EP3023494B1 (en) | 2008-06-13 | 2018-11-28 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
| WO2011005762A1 (en) | 2009-07-06 | 2011-01-13 | Trilink Biotechnologies | Chemically modified ligase cofactors, donors and acceptors |
| JP2013505016A (en)* | 2009-09-16 | 2013-02-14 | マッシー ユニヴァーシティー | Fusion polypeptides and uses thereof |
| LT2705157T (en) | 2011-05-06 | 2017-03-10 | New England Biolabs, Inc. | Ligation enhancement |
| EP2726651B1 (en) | 2011-06-28 | 2018-11-07 | Codexis, Inc. | Protein variant generation by region shuffling |
| US20150010525A1 (en)* | 2012-01-23 | 2015-01-08 | The Regents Of The University Of California | Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification |
| US20150133698A1 (en) | 2012-04-20 | 2015-05-14 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
| AU2014233213A1 (en)* | 2013-03-15 | 2015-09-17 | Theranos Ip Company, Llc | Thermostable blunt-end ligase and methods of use |
| AU2014324669B2 (en)* | 2013-09-27 | 2020-06-04 | Codexis, Inc. | Automated screening of enzyme variants |
| EP3848457B1 (en)* | 2016-02-08 | 2025-08-13 | Rgene, Inc. | Multiple ligase compositions, systems, and methods |
| GB201612011D0 (en)* | 2016-07-11 | 2016-08-24 | Glaxosmithkline Ip Dev Ltd | Novel processes for the production of oligonucleotides |
| US10837009B1 (en)* | 2017-12-22 | 2020-11-17 | New England Biolabs, Inc. | DNA ligase variants |
| Publication number | Publication date |
|---|---|
| DK3635101T3 (en) | 2021-09-20 |
| EP3957723A2 (en) | 2022-02-23 |
| CN110914415B (en) | 2024-09-17 |
| JP2023166579A (en) | 2023-11-21 |
| EP3635101A1 (en) | 2020-04-15 |
| WO2018208665A1 (en) | 2018-11-15 |
| EP3635101A4 (en) | 2020-09-30 |
| KR20200003903A (en) | 2020-01-10 |
| ES2887078T3 (en) | 2021-12-21 |
| AU2018266606A1 (en) | 2019-11-14 |
| JP2020518278A (en) | 2020-06-25 |
| CA3062550A1 (en) | 2018-11-15 |
| EP3635101B1 (en) | 2021-08-18 |
| US20180320162A1 (en) | 2018-11-08 |
| PL3635101T3 (en) | 2021-12-13 |
| EP3957723A3 (en) | 2022-04-20 |
| MX2019013289A (en) | 2020-01-15 |
| AU2018266606B2 (en) | 2024-09-05 |
| HUE055411T2 (en) | 2021-11-29 |
| BR112019023337A2 (en) | 2020-06-16 |
| CN110914415A (en) | 2020-03-24 |
| US12344872B2 (en) | 2025-07-01 |
| JP7401902B2 (en) | 2023-12-20 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909957TA (en) | Engineered ligase variants | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201909868YA (en) | Compositions and methods of treating huntington's disease | |
| SG11201909777YA (en) | Modulatory polynucleotides | |
| SG11201807573VA (en) | Methods for providing single-stranded rna | |
| SG11201908539VA (en) | Auto-injector | |
| SG11201805422WA (en) | Multivalent and multispecific ox40-binding fusion proteins | |
| SG11201910027YA (en) | Bispecific antibody against ox40 and ctla-4 | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201909870SA (en) | Compositions and methods of treating amyotrophic lateral sclerosis (als) | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201803593QA (en) | Engineered nucleic-acid targeting nucleic acids | |
| SG11201901006RA (en) | Systems and methods for enhanced organizational transparency using a credit chain | |
| SG11201407417VA (en) | Encoding and reconstruction of residual data based on support information | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201901364VA (en) | Engineered target specific nucleases | |
| SG11201806639VA (en) | New streptococcal proteases | |
| SG11201810525XA (en) | Anti-gitr antibodies and uses thereof | |
| SG11201811232XA (en) | Treatment of amd using aav2 variant with aflibercept | |
| SG11201808709VA (en) | T cell receptors | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201407859YA (en) | Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists | |
| SG11201803975SA (en) | Improved tnf binders | |
| SG11201407579QA (en) | Interleukin-2 fusion proteins and uses thereof | |
| SG11201909856XA (en) | Mesenchymal lineage precursor or stem cells with enhanced immunosuppression |